First Personal Financial Services’s Ra Pharmaceuticals, Inc. Common Stock RARX Stock Holding History

First Personal Financial Services’s Portfolio RARX Stock Details RARX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q2	–	Sell	-673	Closed	-$4K	–	1012
2018 Q1	$4K	Sell	673 -450	-40%	-$3.22K	﹤0.01%	953
2017 Q4	$10K	Sell	1,123 -5	-0.4%	-$61	﹤0.01%	790
2017 Q3	$16K	Hold	1,128	–	–	﹤0.01%	628
2017 Q2	$21K	Buy	1,128 +521	+86%	+$11.8K	﹤0.01%	577
2017 Q1	$13K	Hold	607	–	–	﹤0.01%	665
2016 Q4	$9K	Buy	+607	New	+$8.25K	﹤0.01%	743

Other funds holding RARX

NMC

NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return

RCM

RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

NHAS

Novo Holdings A/S Hellerup, Denmark $1.23B AUM 81.32% 1-Year Est. Return

CCM

Consonance Capital Management New York $7.28M AUM 43.59% 1-Year Est. Return

First Manhattan New York $36.1B AUM 11.5% 1-Year Est. Return

RSCM

Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

VMI

VHCP Management II New York $379M AUM 421.62% 1-Year Est. Return

First Personal Financial Services's RARX Position: Q2 2018 in Review

First Personal Financial Services sold out of Ra Pharmaceuticals, Inc. Common Stock (RARX) in Q2 2018, closing a stake of 673 shares — an estimated $4K sold.

First Personal Financial Services first reported a position in RARX in Q4 2016 and held it in 6 quarters. The position peaked at $21K in Q2 2017. 62 funds tracked by Wall St. Rank hold RARX as of Q2 2018.

First Personal Financial Services reported no remaining Ra Pharmaceuticals, Inc. Common Stock position as of Q2 2018 after selling out during the quarter.
First Personal Financial Services sold 673 Ra Pharmaceuticals, Inc. Common Stock shares in Q2 2018, an estimated $4K.
First Personal Financial Services first reported a position in Ra Pharmaceuticals, Inc. Common Stock in Q4 2016 and held it in 6 quarters.
First Personal Financial Services's Ra Pharmaceuticals, Inc. Common Stock position peaked at $21K in Q2 2017.
62 funds tracked by Wall St. Rank held Ra Pharmaceuticals, Inc. Common Stock as of Q2 2018.

Based on First Personal Financial Services's 13F filing for Q2 2018, filed 7 Aug 2018.